Search Results 581-590 of 19727 for Hepatitis+C

1. Hepatocellular carcinoma (HCC) - Survival rates - Mayo Clinic

   Hepatitis C prevention and control. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis-c/prevention/index.html. Accessed Nov. 18 ...

2. ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack - Mayo Clinic

   -Known (acute or chronic) hepatitis B or hepatitis C -History or evidence of untreated latent tuberculosis (TB) such as (but not limited to): a) History of ...

3. Nausea and vomiting In-depth - Mayo Clinic

   Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? ... How do COVID-19 antibody tests differ from diagnostic ...

4. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary - Mayo Clinic

   Known prior/current history of hepatitis related to hepatitis B or hepatitis C. Uncontrolled intercurrent illness including, but not limited to the following ...

5. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

   Known infection or chronic infection with hepatitis B virus (hepatitis B surface antigen. [HBsAg] positive) or hepatitis C virus (HCV) (anti-HCV positive).

6. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   Alcoholic steatohepatitis · Autoimmune hepatitis · Hepatitis B virus (HBV) infection · Hepatitis C virus (HCV) infection · Primary biliary cirrhosis · Primary ...

7. Systemic Inflammation Related to Mood Disorders - Mayo Clinic

   Active infection such as HIV, Hepatitis B and Hepatitis C; Inflammatory disease including inflammatory bowel disease, systemic lupus erythematous and ...

8. Transplant Medicine Resource Center - Medical Professionals - Mayo Clinic

   Parag C. Patel, M.D., a transplant cardiologist at Mayo Clinic ... Advancements at Mayo Clinic – Hepatitis C is no longer a barrier to transplant.

9. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Participants who are hepatitis C antibody positive will need to have a negative PCR result before randomization. Those who are hepatitis C PCR positive will be ...

10. Clostridium difficile Archives - Mayo Clinic News Network

    being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast. The post Fecal Microbiota Transplant / ...